Appetite-Related Brain Activity in Women With Anorexia Nervosa

Anorexia Nervosa Clinical Trial

Official title:

The Study of Appetite-Related Brain Activity With Functional Magnetic Resonance Imaging in Women With Anorexia Nervosa

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00344656
• Other study ID #: #4850
• Status: Completed
• Phase: N/A
• First received: June 23, 2006
• Last updated: April 18, 2012
• Start date: October 2004
• Est. completion date: October 2010

Study information

• Verified date: April 2012
• Source: New York State Psychiatric Institute
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Federal Government
• Study type: Observational

Clinical Trial Summary

This study will use functional magnetic resonance imaging to compare appetite-related brain activity in women with anorexia nervosa before and after receiving treatment for the disorder.

Description:

Anorexia nervosa (AN) is a serious eating disorder that is characterized by an extreme loss of appetite. People with AN view themselves as overweight and cannot bring themselves to eat, even though most are dangerously thin. Functional magnetic resonance imaging (fMRI) is a technique that can be used to determine which parts of the brain are activated by physical stimuli. When a certain stimulus is introduced, blood flow to the corresponding area of the brain increases. This increase in blood flow is depicted on the fMRI scan. A person with AN may have different responses to food when evaluated prior to treatment versus after treatment. This study will use fMRI to compare appetite-related brain activity in women with AN before and after receiving treatment for the disorder.

Participants in this study will undergo two fMRI scans. Participants with AN will have one scan before entering the "weight gain phase" of treatment for AN and another scan upon completion of treatment. Healthy volunteers will undergo scans during a similar time frame. Participants will not be allowed to eat from midnight on the night before the scan until after the fMRI procedure, but they may drink water. During the scan, participants will be shown various objects and real foods; they will also be asked to touch the objects and food with their eyes closed. Each visit will last approximately 45 minutes. Ear protectors will be provided to reduce scanner noise.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 15
• Est. completion date: October 2010
• Est. primary completion date: April 2010
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Female
• Age group: 18 Years to 45 Years

Eligibility

Inclusion Criteria:

For Participants with AN:

• DSM-IV diagnosis of AN (restricting or binge eating/purging subtype)

• Medically stable (not continuing to lose weight and vital signs stable)

For Healthy Participants:

• Currently weighs 80-120% of ideal weight

• no history of binge eating disorder or vomiting

• no current or past psychiatric illness

Exclusion Criteria:

For Participants with AN:

• Currently taking medication

• Current substance abuse or dependence disorder

• History of suicide attempt or other self-injurious behavior within 6 months prior to study entry

• Non-removable metal on or inside the body (e.g., metal pacemaker, surgical clips, metallic-ink tattoos)

For Healthy Participants:

• Current or past psychiatric illness

• History of binge eating or vomiting

• Any significant medical or neurologic illness

• Currently taking medication

• History of drug or alcohol abuse within 3 months prior to study entry

• Non-removable metal on or inside the body (e.g., metal pacemaker, surgical clips, metallic-ink tattoos)

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

• Anorexia
• Anorexia Nervosa
• Eating Disorders

Locations

Country	Name	City	State
United States	New York State Psychiatric Institute	New York	New York

Sponsors (1)

Lead Sponsor	Collaborator
New York State Psychiatric Institute

Country where clinical trial is conducted

United States,